Trans and conjugated fatty acids: origins and nutritional effects;Acides gras trans et conjugués : origine et effets nutritionnels

Nutrition Clinique et Metabolisme

Volumn 21, Issue 1, 2007, Pages 46-51

  Chardigny, Jean Michel ^a,c   Malpuech Brugere, Corinne ^b,c  

^a CEMAGREF   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CRNH AUVERGNE   (France)

Author keywords

Cardiovascular risk; Trans fatty acids; Vegetable oils

Indexed keywords

CONJUGATED FATTY ACID; FATTY ACID; TRANS FATTY ACID; UNCLASSIFIED DRUG; VEGETABLE OIL;

ARTICLE; BODY COMPOSITION; CANCER; CARDIOVASCULAR RISK; CHEMICAL MODIFICATION; CHEMICAL PROCEDURES; DIET SUPPLEMENTATION; DIGESTION; FAT INTAKE; FATTY ACID SYNTHESIS; HUMAN; HYDROGENATION; ISOMER; NONHUMAN; NUTRITION; PHYSICAL CHEMISTRY;

ANIMALIA;

EID: 34047168792     PISSN: 09850562     EISSN: 17683092     Source Type: Journal    
DOI: 10.1016/j.nupar.2007.01.008     Document Type: Article

References (54)

1. Ascherio A., Hennekens C.H., Buring J.E., et al. Trans-fatty acids intake and risk of myocardial infarction. Circulation 89 (1994) 94-101
2. Benito P., Nelson G.J., Kelley D.S., et al. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 36 (2001) 229-236
3. Bhattacharyya A., Banu J., Rahman M., et al. Biological effects of conjugated linoleic acids in health and disease. J. Nutr. Biochem. (2006) (In press)
4. Billeaud C, Combe N, Boue C, et al. Trans fatty acids in French pregnant women alter fetal linoleic acid metabolism without affecting growth. In: Annual meeting of the American Pediatric Society and Society for Pediatric Research. 2000. Boston, MA.
5. Blankson H., Stakkestad J.A., Fagertun H., et al. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J. Nutr. 130 (2000) 2943-2948
6. Bolton-Smith C., Woodward M., Fenton S., et al. Does dietary trans fatty acid intake relate to the prevalence of coronary heart disease in Scotland?. Eur. Heart J. 17 (1996) 837-845
7. Bretillon L., Chardigny J.M., Gregoire S., et al. Effects of conjugated linoleic acid isomers on the hepatic microsomal desaturation activities in vitro. Lipids 34 (1999) 965-969
8. Chajes V., Lavillonniere F., Ferrari P., et al. Conjugated linoleic acid content in breast adipose tissue is not associated with the relative risk of breast cancer in a population of French patients. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 672-673
9. Chardigny J.M., Arnal M.A., Juanéda P., et al. Effects of cis-9,trans-11- and trans-10,cis-12-CLA isomers in two strains of mice. 17th International Congress on Nutrition (ICN): 27-31 Août 2001 (2003), Forum Nutr Karger Basel, Vienne
10. Chardigny J.M., Hasselwander O., Genty M., et al. Effects of conjugated fatty acids on feed intake, body composition and liver fatty acids in mice. Lipids 38 (2003) 895-902
11. Chardigny J.M., Malpuech-Brugere C., Dionisi F., et al. Rationale and design of the TRANSFACT project phase I: a study to assess the effect of the two dietary different sources of trans fatty acids on cardiovascular risk actors in humans. Comtemp Clin. Trials 27 (2006) 364-373
12. Clement L., Poirier H., Niot I., et al. Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J. Lipid Res. 43 (2002) 1400-1409
13. Degrace P., Demizieux L., Gresti J., et al. Association of liver steatosis with lipid oversecretion and hypotriglyceridaemia in C57BL/6j mice fed trans-10,cis-12-linoleic acid. FEBS Lett. 546 (2003) 335-339
14. Degrace P., Moindrot B., Mohamed I., et al. Up-regulation of liver VLDL receptor and FAT/CD36 expressions in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid. J. Lipid Res. 47 (2006) 2647-2655
15. Desroches S., Chouinard P.Y., Galibois I., et al. Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid profile and body composition of overweight and obese men. Am. J. Clin. Nutr. 82 (2005) 309-319
16. Gaullier J.M., Halse J., Hoye K., et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am. J. Clin. Nutr. 79 (2004) 1118-1125
17. Gavino V.C., Gavino G., Leblanc M.J., et al. An isomeric mixture of conjugated linoleic acids but not pure cis-9, trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J. Nutr. 130 (2000) 27-29
18. Ha Y.L., and Grimm N.K. Pariza M.W., Newly recognized anticarcinogenic fatty acids: identification and quantification in natural and processed cheeses. J. Agric. Food Chem. 37 (1989) 75-81
19. Houseknecht K.L., Vandenheuvel J.P., Moyacamarena S.Y., et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem. Biophys. Res. Commun. 244 (1998) 678-682
20. Hu F.B., Stampfer M.J., Manson J.E., et al. Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med. 337 (1997) 1491-1499
21. Ip C., Banni S., Angioni E., et al. Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J. Nutr. 129 (1999) 2135-2142
22. Ip C., Chin S.F., Scimeca J.A., et al. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res. 51 (1991) 6118-6124
23. Koletzko B. Trans fatty acids may impair biosynthesis of long-chain polyunsaturated and growth in man. Acta Paediatr. 81 (1992) 302-306
24. Kritchevsky D., Tepper S.A., Wright S., et al. Conjugated linoleic acid isomer effects in atherosclerosis: growth and regression of lesions. Lipids 39 (2004) 611-616
25. Ledoux M., Chardigny J.M., Darbois M., et al. Fatty acid composition of French butters, with special emphasis on conjugated linoleic acid (CLA) isomers. J. Food Comp. Anal. 18 (2005) 409-425
26. Malpuech-Brugere C., Verboeket-Van De Venne W.P., Mensink R.P., et al. Effects of two conjugated linoleic Acid isomers on body fat mass in overweight humans. Obes. Res. 12 (2004) 591-598
27. Mensink R., and Katan M.B. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N. Engl. J. Med. 323 (1990) 439-445
28. Moon E.J., Lee Y.M., and Kim K.W. Antiangiogenic activity of conjugated linoleic acid on basic fibroblast growth factor-induced angiogenesis. Oncol. Rep. 10 (2003) 617-621
29. Mougios V., Matsakas A., Petridou A., et al. Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J. Nutr. Biochem. 12 (2001) 585-594
30. Naumann E., Carpentier Y.A., Saebo A., et al. Cis-9, trans- 11 and trans-10, cis-12 conjugated linoleic acid (CLA) do not affect the plasma lipoprotein profile in moderately overweight subjects with LDL phenotype B. Arteriosclerosis 188 (2006) 167-174
31. Nicolosi R.J., Rogers E.J., Kritchevsky D., et al. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 22 (1997) 266-277
32. Ohashi A., Matsushita Y., Kimura K., et al. Conjugated linoleic acid deteriorates insulin resistance in obese/diabetic mice in association with decrease production of adiponectin and leptin. J. Nutr. Sci. Vitaminol. (Tokyo) 50 (2004) 416-421
33. Oomen C.M., Ocke M.C., Feskens E.J., et al. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 357 (2001) 746-751
34. Pariza M.W., Park Y., and Cook M.E. The biologically active isomers of conjugated linoleic acid. Prog. Lipid Res. 40 (2001) 283-298
35. Park Y., Albright K.J., Liu W., et al. Effect of conjugated linoleic acid on body composition in mice. Lipids 32 (1997) 853-858
36. Park Y., Albright K.J., Storkson J.M., et al. Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids 34 (1999) 243-248
37. Patureaud-Mirand P., Arnal-Bagnard M.A., Mosoni L., et al. Cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid isomers do not modify body composition in adult sedentary or exercised rats. J. Nutr. 134 (2004) 2263-2269
38. Petridou A., Mougios V., and Sagredos A. Supplementation with CLA: isomer incorporation into serum lipids and effect on body fat of women. Lipids 38 (2003) 805-811
39. Pietinen P., Ascherio A., Korhonen P., et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am. J. Epidemiol. 145 (1997) 876-887
40. Poirier H., Shapiro J.S., Kim R.J., et al. Nutritional supplementation with trans-10,cis-12-conjugated linoleic acid induces inflammation of white adipose tissue. Diabetes 55 (2006) 1634-1641
41. Riserus U., Arner P., Brismar K., et al. Treatment with dietary trans10,cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with metabolic syndrome. Diabetes Care 25 (2002) 1516-1521
42. Riserus U., Vessby B., Arner P., et al. Supplementation with trans10 cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 47 (2004) 1016-1019
43. Roy A., Chardigny J.M., Bauchart D., et al. Butters rich either in trans10-C18:1 or in trans11-C18:1 plus cis9,trans11-CLA differentially affect plasma lipids and aortic fatty streak in experimental atherosclerosis in rabbits. Animal (2007) (In press)
44. Roy A., and Ferlay A. Chilliard Y., Production of butter fat rich in trans10-C18:1 for use in biomedical studies in rodents. Reprod. Nutr. Dev. 46 (2006) 211-218
45. Smedman A. Vessby B., Conjugated linoleic acid supplementation in humans: metabolic effects. Lipids 36 (2001) 773-781
46. Terpstra A.H. Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature. Am. J. Clin. Nutr. 79 (2004) 352-361
47. Thom E., Wadstein J., and Gudmundsen O. Conjugated linoleic acid reduces body fat in healthy exercising humans. J. Int. Med. Res. 29 (2001) 392-396
48. Toomey S., Roche H., Fitzgerald D., et al. Regression of pre-established atherosclerosis in the apoE-/- mouse by conjugated linoleic acid. Biochem. Soc. Trans. 31 (2003) 1075-1079
49. Tricon S., Burdge G.C., Kew S., et al. Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am. J. Clin. Nutr. 80 (2004) 614-620
50. Tsuboyama-Kasaoka N., Takahashi M., Tanemura K., et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49 (2000) 1534-1542
51. Valeille K., Gripois D., Blouquit M.F., et al. Lipid atherogenic risk markers can be more favourably influenced by the cis-9,trans-11-octadecadienoate isomer than a conjugated linoleic acid mixture or fish oil in hamsters. Br. J. Nutr. 91 (2004) 191-199
52. West D.B., Delany J.P., Camet P.M., et al. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am. J. Physiol. 275 (1998) R667-R672
53. Willett W.C., Stampfer M.J., Manson J.E., et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341 (1993) 581-585
54. Zock P.L. Katan M.B., Trans fatty acids, lipoproteins, and coronary risk. Can. J. Physiol. Pharmacol. 75 (1997) 211-216